TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/17/14 16:30 | 11/13/14 | PCYC | Pharmacyclics Inc | DE | Health | Drug | Pharmaceutical Preparations | Fardis Maria | CA | O | Chief of | S.d | -424 | 141.30 | 0 | -3 | -48 | 3 | D | ||||||||||||||
11/10/14 18:28 | 11/7/14 | PCYC | Pharmacyclics Inc | DE | Health | Drug | Pharmaceutical Preparations | Fardis Maria | CA | O | Chief of | S.d | -673 | 134.50 | 0 | -5 | -61 | 3 | D | ||||||||||||||
8/15/14 14:41 | 8/13/14 | PCYC | Pharmacyclics Inc | DE | Health | Drug | Pharmaceutical Preparations | Fardis Maria | CA | O | Chief of | S.d | -484 | 121.01 | 0 | -4 | -56 | 3 | D | ||||||||||||||
3/7/14 18:06 | 3/5/14 | PCYC | Pharmacyclics Inc | DE | Health | Drug | Pharmaceutical Preparations | Fardis Maria | CA | O | Chief of | S.d | -422 | 140.50 | 0 | -3 | -50 | 3 | D | ||||||||||||||
1/9/13 19:05 | 1/8/13 | PCYC | Pharmacyclics Inc | DE | Health | Drug | Pharmaceutical Preparations | Fardis Maria | CA | O | EVP,Oper | S | -163 | 65.00 | 0 | -3 | -72 | 1 | D | ||||||||||||||
1/7/13 20:23 | 1/7/13 | PCYC | Pharmacyclics Inc | DE | Health | Drug | Pharmaceutical Preparations | Fardis Maria | CA | O | EVP,Oper | S.d | -225 | 64.20 | 0 | -4 | -50 | 3 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |